Urinary tract infections in surgical patients

Surgical Clinics of North America

Volumn 94, Issue 6, 2014, Pages 1351-1368

  Ramanathan, Rajesh ^a   Duane, Therese M ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b JPS Health Network   (United States)

Author keywords

Catheter associated urinary tract infection; CAUTI; Hospital acquired conditions; Patient safety; Urinary tract infections; Urosepsis

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; ASYMPTOMATIC INFECTION; BLADDER CATHETERIZATION; CATHETER CARE; CATHETER INFECTION; CLINICAL EVALUATION; DISEASE ASSOCIATION; EPIDURAL ANESTHESIA; HEALTH CARE PERSONNEL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INDWELLING URINARY CATHETER; MEDICAL EDUCATION; PATHOGENESIS; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT DURATION; TREATMENT INDICATION; URINARY TRACT INFECTION; CATHETER-RELATED INFECTIONS; CROSS INFECTION; INDWELLING CATHETER; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; URINARY CATHETER; URINARY TRACT INFECTIONS;

CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CROSS INFECTION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; URINARY CATHETERIZATION; URINARY CATHETERS; URINARY TRACT INFECTIONS;

EID: 84923640957     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.08.007     Document Type: Review

References (62)

1. Kohn L., Corrigan J., Donaldson M. To err is human: building a safer health system 2000, Institute of Medicine, Washington, DC.
2. Khuri S.F. The NSQIP: a new frontier in surgery. Surgery 2005, 138(5):837-843.
3. Agency for Healthcare Research and Quality (AHRQ) AHRQ quality indicators: guide to patient safety indicators 2003, AHRQ, Rockville (MD).
4. Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Reg 2007, 72(162):47129-48175.
5. Nicolle L.E. Urinary catheter-associated infections. Infect Dis Clin North Am 2012, 26(1):13-27.
6. Lo E., Nicolle L., Classen D., et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S41-S50.
7. Gould C.V., Umscheid C.A., Agarwal R.K., et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010, 31(4):319-326.
8. Chenoweth C., Saint S. Preventing catheter-associated urinary tract infections in the intensive care unit. Crit Care Clin 2013, 29(1):19-32.
9. National Nosocomial Infections Surveillance System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32(8):470-485.
10. Hooton T.M., Bradley S.F., Cardenas D.D., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010, 50(5):625-663.
11. Wald H.L., Kramer A.M. Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections. JAMA 2007, 298(23):2782-2784.
12. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000, 28(1):68-75.
13. Guillamondegui O.D., Gunter O.L., Hines L., et al. Using the National Surgical Quality Improvement Program and the Tennessee Surgical Quality Collaborative to improve surgical outcomes. JAm Coll Surg 2012, 214(4):709-714. [discussion: 714-6].
14. Trickey A.W., Crosby M.E., Vasaly F., et al. Using NSQIP to investigate SCIP deficiencies in surgical patients with a high risk of developing hospital-associated urinary tract infections. Am J Med Qual 2014, 29:381-387.
15. Regenbogen S.E., Read T.E., Roberts P.L., et al. Urinary tract infection after colon and rectal resections: more common than predicted by risk-adjustment models. JAm Coll Surg 2011, 213(6):784-792.
16. Jarvis W.R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996, 17(8):552-557.
17. Saint S., Chenoweth C.E. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003, 17(2):411-432.
18. Garibaldi R.A., Burke J.P., Dickman M.L., et al. Factors predisposing to bacteriuria during indwelling urethral catheterization. NEngl J Med 1974, 291(5):215-219.
19. Platt R., Polk B.F., Murdock B., et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986, 124(6):977-985.
20. Shapiro M., Simchen E., Izraeli S., et al. Amultivariate analysis of risk factors for acquiring bacteriuria in patients with indwelling urinary catheters for longer than 24 hours. Infect Control 1984, 5(11):525-532.
21. Tambyah P.A., Halvorson K.T., Maki D.G. Aprospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999, 74(2):131-136.
22. Sievert D.M., Ricks P., Edwards J.R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34(1):1-14.
23. Dalhoff A. Global fluoroquinolone resistance epidemiology and implications for clinical use. Interdiscip Perspect Infect Dis 2012, 2012:976273.
24. Morris N.S., Stickler D.J., McLean R.J. The development of bacterial biofilms on indwelling urethral catheters. World J Urol 1999, 17(6):345-350.
25. O'Toole G.A., Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998, 30(2):295-304.
26. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15(2):167-193.
27. Sabbuba N., Hughes G., Stickler D.J. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int 2002, 89(1):55-60.
28. Hoyle B.D., Wong C.K., Costerton J.W. Disparate efficacy of tobramycin on Ca(2+)-, Mg(2+)-, and HEPES-treated Pseudomonas aeruginosa biofilms. Can J Microbiol 1992, 38(11):1214-1218.
29. Donlan R.M. Role of biofilms in antimicrobial resistance. ASAIO J 2000, 46(6):S47-S52.
30. Loeb M., Bentley D.W., Bradley S., et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol 2001, 22(2):120-124.
31. Raz R., Schiller D., Nicolle L.E. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. JUrol 2000, 164(4):1254-1258.
32. Hannan E.L., Waller C.H., Farrell L.S., et al. Acomparison among the abilities of various injury severity measures to predict mortality with and without accompanying physiologic information. JTrauma 2005, 58(2):244-251.
33. US Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) manual 2013, US Centers for Disease Control and Prevention, Atlanta (GA).
34. Loeb M., Brazil K., Lohfeld L., et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ 2005, 331(7518):669.
35. Leone M., Perrin A.S., Granier I., et al. Arandomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med 2007, 33(4):726-729.
36. Sobel J.D., Kauffman C.A., McKinsey D., et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000, 30(1):19-24.
37. Peterson J., Kaul S., Khashab M., et al. Adouble-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008, 71(1):17-22.
38. Harding G.K., Nicolle L.E., Ronald A.R., et al. How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 1991, 114(9):713-719.
39. Dow G., Rao P., Harding G., et al. Aprospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 2004, 39(5):658-664.
40. Stubbs B.M., Badcock K.J., Hyams C., et al. Aprospective study of early removal of the urethral catheter after colorectal surgery in patients having epidural analgesia as part of the enhanced recovery after surgery programme. Colorectal Dis 2013, 15(6):733-736.
41. Zaouter C., Wuethrich P., Miccoli M., et al. Early removal of urinary catheter leads to greater post-void residuals in patients with thoracic epidural. Acta Anaesthesiol Scand 2012, 56(8):1020-1025.
42. Basse L., Werner M., Kehlet H. Is urinary drainage necessary during continuous epidural analgesia after colonic resection?. Reg Anesth Pain Med 2000, 25(5):498-501.
43. Pratt R.J., Pellowe C.M., Wilson J.A., et al. Epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. JHosp Infect 2007, 65(Suppl 1):S1-S64.
44. Winter M., Helms B., Harrington L., et al. Eliminating catheter-associated urinary tract infections: part I. Avoid catheter use. JHealthc Qual 2009, 31(6):8-12.
45. Rhodes N., McVay T., Harrington L., et al. Eliminating catheter-associated urinary tract infections: part II. Limit duration of catheter use. JHealthc Qual 2009, 31(6):13-17.
46. Stephan F., Sax H., Wachsmuth M., et al. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study. Clin Infect Dis 2006, 42(11):1544-1551.
47. Gokula R.M., Smith M.A., Hickner J. Emergency room staff education and use of a urinary catheter indication sheet improves appropriate use of Foley catheters. Am J Infect Control 2007, 35(9):589-593.
48. Hartstein A.I., Garber S.B., Ward T.T., et al. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 1981, 2(5):380-386.
49. Munasinghe R.L., Yazdani H., Siddique M., et al. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol 2001, 22(10):647-649.
50. Gardam M.A., Amihod B., Orenstein P., et al. Overutilization of indwelling urinary catheters and the development of nosocomial urinary tract infections. Clin Perform Qual Health Care 1998, 6(3):99-102.
51. Pickard R., Lam T., Maclennan G., et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technol Assess 2012, 16(47):1-197.
52. Srinivasan A., Karchmer T., Richards A., et al. Aprospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 2006, 27(1):38-43.
53. Niel-Weise B.S., van den Broek P.J. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 2005, (3). CD004203.
54. Saint S., Kaufman S.R., Rogers M.A., et al. Condom versus indwelling urinary catheters: a randomized trial. JAm Geriatr Soc 2006, 54(7):1055-1061.
55. Crouzet J., Bertrand X., Venier A.G., et al. Control of the duration of urinary catheterization: impact on catheter-associated urinary tract infection. JHosp Infect 2007, 67(3):253-257.
56. Maki D.G., Tambyah P.A. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001, 7(2):342-347.
57. Yamamoto S., Tsukamoto T., Terai A., et al. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. JUrol 1997, 157(3):1127-1129.
58. Cass A.S., Ireland G.W. Antibacterial perineal washing for prevention of recurrent urinary tract infections. Urology 1985, 25(5):492-494.
59. Slappendel R., Weber E.W. Non-invasive measurement of bladder volume as an indication for bladder catheterization after orthopaedic surgery and its effect on urinary tract infections. Eur J Anaesthesiol 1999, 16(8):503-506.
60. Saint S., Wiese J., Amory J.K., et al. Are physicians aware of which of their patients have indwelling urinary catheters?. Am J Med 2000, 109(6):476-480.
61. Fakih M.G., Dueweke C., Meisner S., et al. Effect of nurse-led multidisciplinary rounds on reducing the unnecessary use of urinary catheterization in hospitalized patients. Infect Control Hosp Epidemiol 2008, 29(9):815-819.
62. Meddings J., Rogers M.A., Macy M., et al. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis 2010, 51(5):550-560.